Outlook Therapeutics (OTLK) Preferred Stock Liabilities (2015 - 2019)
Outlook Therapeutics (OTLK) recorded Preferred Stock Liabilities of $5.53 million in fiscal Q1 2020 (quarter ended Dec 31, 2019), up 13.1% from $4.88 million a year earlier and up 3.1% from the prior quarter.
Powered by 
Analysis
Outlook Therapeutics (OTLK) Preferred Stock Liabilities (2015 - 2019) Analysis & Trends
At the end of FY2019 (ended Sep 30, 2019), Outlook Therapeutics reported Preferred Stock Liabilities of $5.36 million, up 13.2% from FY2018.
- Across earlier fiscal years, Preferred Stock Liabilities came in at $4.73 million in FY2018 (+61.9%) and $2.92 million in FY2017.
- The fiscal Q1 2020 figure is the highest quarterly Preferred Stock Liabilities since fiscal Q2 2018.
- On a year-over-year basis, Preferred Stock Liabilities has increased for three consecutive quarters, with an average decline of 4.0% over the last six quarters.
- Per Business Quant, the preceding three fiscal quarters came in at $5.36 million (Q4 2019), $5.2 million (Q3 2019) and $5.04 million (Q2 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Outlook Therapeutics | 62.90 Mn | 27.15 Mn | -8,265.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 5.53 Mn |
| Sep 30, 2019 | 5.36 Mn |
| Jun 30, 2019 | 5.20 Mn |
| Mar 31, 2019 | 5.04 Mn |
| Dec 31, 2018 | 4.88 Mn |
| Sep 30, 2018 | 4.73 Mn |
| Jun 30, 2018 | 3.93 Mn |
| Mar 31, 2018 | 18.29 Mn |
| Dec 31, 2017 | 17.19 Mn |
| Sep 30, 2017 | 2.92 Mn |
| Jun 30, 2016 | 5.12 Mn |
| Mar 31, 2016 | 1.97 Mn |
| Dec 31, 2015 | -939,539.00 |
| Sep 30, 2015 | 5.07 Mn |
API Access
Outlook Therapeutics Preferred Stock Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "preferred-stock-liabilities", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();